Holmusk partners with NHCS to improve care for heart failure, coronary artery disease

Holmusk, a global digital health and data analytics company, has embarked on a three-year partnership with National Heart Centre Singapore (NHCS) to improve care for heart failure and coronary artery disease using big data analytics to build better predictive models that can be validated for use in the treatment and prevention of cardiovascular disease in Singapore.

Supported by the Singapore Economic Development Board (EDB), Holmusk will collaborate with NHCS to analyse aggregated data from the Singapore Cardiac Longitudinal Outcomes Database (SingCLOUD) to drive insights and build effective tools for clinical decision support.

Nawal Roy, CEO and Founder of Holmusk
Nawal Roy. Photo courtesy: Holmusk

“Innovations in healthcare is happening at a rapid pace globally. Precision medicine is the future of healthcare and big data analytics will play a significant role to improve clinical outcomes as well as operational and financial outcomes.” said Nawal Roy, CEO and Founder of Holmusk.

“Our focus is to bring cutting edge analytic practices that facilitate early detection and early intervention to engage patients before they become chronic. This initiative could turn into a nationwide effort to optimise efficiency and improve clinical outcomes for cardiovascular patients in Singapore, while providing a gold standard of reference for the APAC region. It is a great privilege to work with researchers and clinicians at NHCS. Most importantly, we are very proud to have the esteemed backing of EDB,” he added.  

“Our aim in this project is to track clinical outcomes and design targeted intervention strategies that improve care in patients with heart failure or coronary artery disease,” said Associate Professor Yeo Khung Keong, a Senior Consultant at NHCS.

Ho Weng Si, Director of the Biomedical Sciences division at ED
Ho Weng Si. Photo courtesy: LinkedIn

“Healthcare is a growing and evolving sector where value creation is driven by evidence-backed innovation, with a clear focus on better patient outcomes,” said Ho Weng Si, Director of the Biomedical Sciences division at EDB.

 “This partnership is a promising example of local private and public sector collaboration to create data-driven healthcare solutions which will improve healthcare in Singapore and the region,” she added.

 This partnership is a three-year-long project that will run through to 2019.

Holmusk is a digital health company focused on solving complex problems in healthcare. It builds innovative, scalable and cost-effective digital behaviour change programs that combine cutting-edge clinical research, technology and design to nudge people toward sustainable changes for better health. It develops powerful predictive algorithms that offer actionable insights for personalised care and population health management.